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Background: For intraoperative imaging in operating theaters or preoperative imaging in clinics, compact and
economic integration rather than large and expensive equipment is required to coregister structural and functional
imaging. However, current technologies, such as those integrating optical and gamma cameras or infrared and
fluorescence imaging, involve certain drawbacks, including the radioactive biorisks of nuclear medicine indicators
and the inconvenience of conducting measurements in dark environments.
Methods: To specifically and magnetically label liver tumors, an anti-alpha-fetoprotein (AFP) reagent was
synthesized from biosafe iron oxide magnetic nanoparticles (MNPs) coated with anti-AFP antibody and solved in
a phosphate buffered saline solution. In addition, a novel dual-imaging model system integrating an optical
camera and magnetic scanning superconducting-quantum-interference device (SQUID) biosusceptometry (SSB)
was proposed. The simultaneous coregistration of low-field magnetic images of MNP distributions and optical
images of anatomical regions enabled the tumor distribution to be determined easily and in real time. To
simulate targeted MNPs within animals, fewer reagents than the injected dose were contained in a microtube as
a sample for the phantom test. The phantom test was conducted to examine the system characteristics and the
analysis method of dual images. Furthermore, the animal tests were classified into two types, with liver tumors
implanted either on the backs or livers of rats. The tumors on the backs were to visually confirm the imaging
results of the phantom test, and the tumors on the livers were to simulate real cases in hepatocellular carcinoma
people.
Results: A phantom test was conducted using the proposed analysis method; favorable contour agreement was
shown between the MNP distribution in optical and magnetic images. Consequently, the positioning and
discrimination of liver tumors implanted on the backs and livers of rats were verified by conducting in vivo and
ex vivo tests. The results of tissue staining verified the feasibility of using this method to determine the
distribution of liver tumors.
Conclusion: The results of this study indicate the clinical potential of using anti-AFP-mediated MNPs and the
dual-imaging model SSB for discriminating and locating tumors.
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Tumor imaging is a crucial medical practice that is
performed after positive tumor screening results have
been confirmed by blood tests. By using medical im-
aging, clinicians can analyze the phase and distribution
of tumors to determine treatment options such as sur-
gery. Medical imaging procedures are classified into
structural or functional imaging. Structural imaging is
developed on the basis of the physical characteristics
of the tissues, whereas functional imaging is developed
on the basis of the biological features of tumors or
characteristics of bioprobe-mediated nanoparticles, which
is an image contrast medium. Hence, simultaneous posi-
tioning and discrimination of tumors can be achieved by
incorporating structural imaging and functional imaging.
For example, structural imaging methods, such as com-
puted tomography (CT) [1] or magnetic resonance im-
aging (MRI) [2], can be combined with functional imaging
methods, such as radioactive positron emission tomog-
raphy (PET). However, for biosafety, bioprobe-mediated
magnetic nanoparticles (MNPs) without radioactive risks
are increasingly adopted as a contrast medium in func-
tional imaging [3] for MRI.
In addition, sensitive imaging methodologies such as
MRI, CT, or PET are generally difficult to implement in
both general medical clinics and clinical practices, particu-
larly because the equipment is expensive to install and
maintain. For example, using MRI devices is restricted to
preoperative diagnosis because of the high cost of con-
structing a shielding room with few metal objects, and
also the expense involved in maintaining liquid helium
coolants. Hence, for the intraoperative positioning of tu-
mors, alternate navigation surgery methodologies involve
using robotic or hand-held probes in integrated systems
composed of a gamma camera and ultrasound [4] or an
optical video [5].
To conform to the requirements of the diverse im-
aging technologies used in various clinical practices such
as preoperative diagnosis and intraoperative positioning
of tumors, various functional contrast media have been
developed as multimodal contrast media, such as MNPs
coated with radioactive or fluorescent [6] indicators in
addition to bioprobes [7]. However, using such complex
contrast media is costly, and using multimodal nanoparti-
cles involves high biorisk. Hence, simple contrast mediums
with biosafety and economic viability, such as gadolinium
and iron-oxide MNPs without coated radioactive or fluor-
escent materials, are approved by the USA Food and Drug
Administration [8,9]. According to a previous study,
iron-oxide MNPs are superior to gadolinium because
gadolinium MNPs induce kidney disease [10]. An im-
aging technique for intraoperative positioning of tumors
must therefore be developed to expand the application of
iron-oxide MNPs beyond MRI preoperative diagnosis.Recently, developments for noninvasively examining
MNP distributions have been focused on the magnetic
characteristics of MNPs. For example, to examine the
remanent properties of MNPs, a static superconducting-
quantum-interference device (SQUID) sensor or a pickup
coil in a shielded sensing unit detects the magnetized and
moved sample from distant magnetization coils or mag-
nets [11,12]. This method is suitable for in vitro tests be-
cause of the fast sample movement. The biomedical
application of SQUID relaxometry based on MNP relax-
ation [13-15] is limited to in vitro or ex vivo tests because
in addition to the requirement of the shielding environ-
ment, the involved signals are sensitive to the dynamic
and size distribution, hydrodynamic size, and temperature
of MNPs in animals. Furthermore, magnetic particle im-
aging technologies based on the nonlinear characteristics
of MNPs under high field gradients can be used to image
the three-dimensional distribution of MNPs. However, the
practical application of such technologies is limited be-
cause they are difficult to integrate with other real-time
structural imaging methods (e.g., MRI) [16].
Conversely, because of the alternate-current (AC) sus-
ceptibility of MNPs under low magnetic fields, scanning
SQUID biosusceptometry (SSB) examinations of dynamic
MNP distributions in the liver, heart, and tumors of ani-
mals for pharmacokinetics [17], metabolism [18], and
tumor targeting [19] have yielded satisfactory agreement
with other biological examinations. The earliest SSB tech-
nologies enabled magnetic functional measurement, but
an optical video camera was not incorporated. SSB is ad-
vantageous because it does not require a shielded environ-
ment, animal torsos can be scanned easily because the
device can be handled similarly to an ultrasound probe,
and liquid nitrogen involves low maintenance costs.
Moreover, the AC susceptibility of the MNPs employed in
this study has certain advantages. The AC excitation field
contributed the centrifugal force to bioprobe-coating
MNPs; nontargeted molecules were then removed. Based
on this unique characteristic, immunomagnetoreduction
(IMR) assays required no complex and washing steps in
in vitro blood tests, unlike the enzyme-linked immuno-
sorbent assay currently used in clinics [20,21]. Similarly,
the utility of the centrifugal force in in vivo tests, such as
in this study, could improve the targeting specificity of
bioprobe-coating MNPs for the correctness of tumor
label. Furthermore, AC-susceptibility technology can be
operated in an unshielded environment by using a gen-
eral lock-in amplifier, which is superior in comparison
with remanent- or relaxation-based technologies that
require an expensive shielded environment.
This study proposed a novel SSB method that integrates
an optical video camera into the vertical pickup coils,
which is in contrast to the planar pickup coils of early SSB
technologies. In addition, the integrated and compact
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shielded environment as an ultrasound probe. Novel SSB
methods can be used to immediately fuse magnetic and
optical images. Thus, SSB is a powerful tool for preopera-
tive diagnosis and the intraoperative positioning of tu-
mors. Although the spatial resolutions of 2-dimensional
SSB fusion images are less accurate than those of three-
dimensional MRI images for preoperative diagnosis, using
2-dimensional SSB fusion images is adequate for tumor
positioning and safer than using gamma cameras or fluor-
escence imaging for intraoperative positioning. To verify
the feasibility of using the proposed SSB technique for
surgical navigation, simple anti-alpha-fetoprotein (AFP)-
mediated MNPs were employed to conduct both phantom
and animal tests, in which AFP was used as a biomarker
in rats with tumors of the liver.
Results and discussion
Phantom test
The dual-imaging model SSB shown in Figure 1 was
used to capture optical and magnetic images of microt-
est tubes filled with the anti-AFP reagents. The injection
dose for animals in this study was 0.9 g with anti-AFP
reagents at a concentration of 0.3 emu/g. Figure 2A
shows dual-images of the microtest tube filled with
0.3 emu/g and 0.25 g, which is approximately 28% of the
injection dose, as well as the overlaid images. In Figure 2A,
the optical image shows a top-down view of one of the
microtest tubes, as well as magnetic images of the same
test tube. In the magnetic images, the upper red spot indi-
cates the raw signal intensity I, whereas the lower mag-
netic image indicates filtered signals where I is higher
than 50% of the peak signal intensity Imax in each red spot,
not in the entire image. In other words, the upper mag-
netic spot has more signals with I lower than 50% of Imax
compared with the lower one.
The magnetic signals were distributed spherically from
the sample; therefore, the red spot in the raw magnetic
image covers a larger area than that indicated by the op-
tical image. However, the red spot in the filtered mag-
netic image is similar to the distribution shown in the
optical image. The spatial contour error between the red
spot in the filtered magnetic image and the brown circle
in the optical image is within 3 mm. Hence, the red spot
in the filtered magnetic image indicates the MNP distri-
bution shown in the optical image.
Consequently, the sensitivity of this system was stud-
ied by using the maximum detectable distance of the
same phantom sample. The line graph in Figure 2B
shows that the Imax of the red spots in the magnetic
image decreased as the sample distance between the top
surface of the anti-AFP reagents and the bottom surface
of the scanning probe unit was increased from 31 to
66 mm. Furthermore, Imax decreased as the reagentconcentration was reduced from 0.3 to 0.005 emu/g,
with Fe concentration ranging from 1.95 mg/g to
32.5 μg/g. This shows that the detectable distance was
approximately 56 mm for the samples with a concentra-
tion of 0.1–0.3 emu/g, whereas that for the samples with a
concentration of 0.005–0.01 emu/g was approximately
44 mm, which is sufficient for detecting MNPs in tumors
implanted in the livers or grafted onto the backs of ani-
mals [22,23]. In other words, the sensitivity to the amount
of Fe in the MNPs was approximately 250 μg at 56 mm
and 12.5 μg at 44 mm. Although these discussed distances
between the sample and sensing probe were tens of milli-
meters in this study, and the measurement was performed
in an unshielded environment, the minimal detection of
MNPs was tens of pictograms at the short distance of
2 mm; this is similar to the results reported by previous
research [12]. Furthermore, the detectable distance can be
increased for clinical applications involving humans by
simply modifying the equipment, such as by increasing
the product of the area and current of the cylindrical exci-
tation coil, rather than by injecting more MNPs, which
would increase toxicity. For example, the expected detec-
tion distance can be increased to approximately 15 cm,
which is approximately the half thickness of a general
belly, if this product increases tens of times; this reason is
the excitation field increases with this product while the
sample distance is much larger than the radius of excita-
tion coil based on Biot-Savart law. In addition, if the im-
aged tumor is large, the detection limit improves because
of increased target MNPs.
Figure 2C shows that the integral of I, which repre-
sents the product of the sum of I values greater than
50% of Imax and the pixel spacing, decreased with the
distance between the sample and the scanning probe,
but increased with the sample magnetism, which is the
product of the reagent concentration and weight. The
minimal value was observed at approximately 0.05 Volt.
mm2, which can be considered as the sensitivity of the
integral of I. Moreover, evaluating the level of magnet-
ism in the sample (i.e., MNP amount) was feasible by
using the integral of I as a reference.
Animal test of exterior liver tumors
Figure 3 shows the results of locating a tumor in the
back of one of the rats. The figure shows that at 0 h, be-
fore injection of the MNPs, the integral of I was low, but
it was higher than the background level because of the
presence of weakly paramagnetic materials in the tissue,
such as red blood cells. The tumor region generally
expressed high I values because it was close to the scan-
ning probe, causing it to dominate the integral of I at
0 h. At 24 h, most of the I of the red spot were high
because of the high accumulation of anti-AFP MNPs on
the back tumors [19]. Moreover, by 24 h, the anti-AFP
Figure 1 The dual-model SSB developed for simultaneous optical imaging and magnetic imaging. Scheme for the examination of tumor
rats (A). Bottom view of the scanning probe (B).
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phagocyte system, which is also called the reticuloendo-
thelial system or macrophage system, and then excreted
through other organs [18]. Therefore, at 24 h, the red spot
was distributed in the back tumors only. Furthermore, the
I of one tumor rat (Figure 3A) and the sum of the I of 2
tumor rats (Figure 3B) were apparently larger at 24 h than
at 0 h (ie, before injection). However, the repeatability er-
rors at 24 h and at 0 h were relatively small.In the optical and fused images in Figure 3A, the blue
dotted line and the red spot represents the contour of
the implanted tumors and the distribution of anti-AFP
MNPs, respectively. The blue dotted line and red spot
exhibit adequate consistency, with a spatial error of
5 mm at both 0 h and 24 h. Thus, the SSB can be
employed to locate MNP-targeted tumors. Furthermore,
these results verify that the integral of I is a suitable in-
dicator for detecting anti-AFP MNPs in tumors when
Figure 2 The phantom test. Microtest tubes were filled with
anti-AFP reagents with concentrations of 0.3, 0.2, 0.1, 0.01, and
0.005 emu/g that were 0.25 g in weight. The image process for the
optical image, the magnetic images composed of I and only I larger
than 50%, and the fused image (A). The dependence of Imax of the
red spot in the magnetic image on the sample distance and the
sample concentration (B). The dependence of the integral of I on
the sample distance and the sample magnetism (C).
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Hence, the fused images revealed the spatial and func-
tional results of the MNP-targeted tumors, and this target-
ing phenomenon is in agreement with a similar study that
used an identical dose of the same anti-AFP reagent [23].
Animal test of interior liver tumors
The results of the animal tests for the surgical navigation
of the liver tumors within the liver lobes are depicted in
Figure 4. In the fused images of Rat B1’s unexposed ab-
domen (Figure 4A), few red spots were observed at 0 h;
however, the red spots were clearly observable in the
liver region at 24 h. Consequently, exposing the abdo-
men for in vivo imaging at 24.5 h revealed nearly identi-
cal red spots, indicating that the skin did not interfere
with the magnetic measurement.
Furthermore, after immersing the livers in formalin for
1 week (wk), the red spot on the preseparation liver
lobes in the ex vivo image at 24.5 h was similar to that
of the livers in the in vivo image of the exposed livers at
24.5 h, except in the lower left region (Figure 4A). This
difference was probably because the short sample dis-
tance yielded a strong I in the in vivo test, whereas the
lower-left part of the stacked livers was highly sustained
by the other organs in the body. Conversely, the long
distance yielded a weak I in the ex vivo test, and the
lower-left part of the stacked livers was fixed without
support from other organs. Similarly, the I of the ex vivo
test was weaker because of the long sample distances for
some regions of the stacked livers without the support
of other organs. In other words, the distance between
the scanning probe unit and each liver lobe was shorter
in the in vivo test than in the ex vivo test. The result of
the in vivo test was because of the support of other or-
gans; the result of the ex vivo test was because of the
formalin fixation without support from other organs.
In addition to the whole liver in the original presepara-
tion (Figure 4A), Rat B1’s discrete liver lobes were im-
aged (Figure 4B). The fused images of each liver lobe
show dark spots in Lobes 1–4, and the red spot with the
lowest intensity covered most of Lobe 5. Moreover, by
using the same color scale, Figure 4B shows that the red
on each separated liver lobe was more intense than that
of all of the stacked liver lobes in Figure 4A. This oc-
curred because each separated liver lobe on the same
plane was at an identical distance from the scanning
probe, whereas all of the liver lobes that were stacked to-
gether were at various distances from the probe. The
lower lobes were the furthest from the scanning probe.
Moreover, a piece of the red spot region of the ex vivo
images (Figure 4B) was stained using a hematoxylin and
eosin (HE) stain and AFP stain. The morphology results
of the HE staining revealed that most of the tissues in
Lobes 1–4 exhibited abundant pink cytoplasms, whereas
Figure 3 The animal test for the rats with a liver tumor on the back. The optical image and the fused image at 0 h and 24 h for 1 tumor rat
(A). The average sum of I at 0 and 24 h for 2 tumor rats (B).
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3 and 4 exhibited purple because of normal amounts of
cytoplasm. The 2 regions with light pink and dark purple
in the HE stain corresponded to those with the dark
brown and light brown in the AFP staining, respectively.
Hence, these 2 regions were identified as tumor and nor-
mal tissues, respectively. Although small portions of nor-
mal tissue were present, the tissues were positive for
tumors because of the presence of large tumor tissues.
In other words, Lobes 1–4 were positive, but Lobe 5 was
negative. Moreover, because the no-spot region of Lobes
1–4 in the ex vivo images yielded similar staining results
to that of Lobe 5, this region was also negative. In sum-
mary, both the red-spot and no-spot regions in the
ex vivo fused images of each lobe according to the dual-
imaging model SSB correspond reasonably to the tissuestaining results. The intensity of the red spot in the
ex vivo images depended on the darkness of the AFP
stain in the tumor tissue recognized by the HE stain.
Analytically, for each liver lobe of the 3 rats (Rats B1–3),
its integral of I can be divided into levels higher and
lower than 0.10 Volt.mm2 (Figure 4C). Similarly, its ex-
pression of the 2 tissue stains can determine positive
and negative results. For example, for Rat B1 as shown
in Figure 4B, positive results were confirmed by the ex-
pression of abundant pink cytoplasms in the HE stain
and at least one brown region in the AFP stain in Lobes
1–4. The solid and dot pattern of the bar in Figure 4C
represent the positive and negative results based on the
2 tissue stains. By comparing the integral of I and the
judgment of positivity or negativity, a criterion was
determined that the positive or negative judgment
Figure 4 The animal test for 3 rats with a liver tumor in the liver. Rat B1 was imaged in a supine position at 0 h and 24 h, and with its belly
opened at 24.5 h. Its liver was immersed in diluted formalin with 10% concentration for 1 wk. Both the stacked block and separated lobe livers
were magnetically examined ex vivo (A). After identifying the red-spot and no-spot regions in the separated lobe livers by using the dual-model
SSB for Rat B1, one small piece of liver tissue in the red-spot region was confirmed by HE and AFP staining (B). The comparison between the
integral of I according to the dual-model SSB and the positive and negative judgment according to the tissue staining for separated liver lobes
(Lobes 1–5) of 3 tumor rats (Rats B1–3) (C).
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0.10 Volt.mm2, respectively.
Conclusion
This study developed a novel dual-imaging model SSB
by integrating an optical camera and magnetic SSB to
fuse low-field magnetic images of MNP distributions
and optical images for simultaneous functional and
structural imaging. The feasibility of this novel dual-
imaging model SSB was verified by the favorable spatial
agreement in phantom and animal tests, as well as con-
firmation from tissue staining. Hence, the application
of imaging technologies of simple Fe3O4 MNPs were
expanded from preoperative diagnosis by MRI to intra-
operative positioning of tumors and preoperative im-
aging in clinics by using this novel dual-imaging model
SSB, demonstrating the high potential of this method
in the surgical navigation of MNP-targeted tumors in
future clinical applications.
Methods
Synthesis and characteristics of anti-AFP reagent
The anti-AFP reagent used in this study was anti-AFP-
meditated MNPs in a phosphate buffered saline solution.
The magnetic core, surfactant, and bioprobe coating of
anti-AFP-meditated MNPs were Fe3O4, dextran, and AFP
antibody (EA502-Q1053, EastCoast Bio, USA), respect-
ively. The basic materials of Fe3O4 MNPs solved in a
water solution were obtained from MagQu Co., Taiwan,
and the details of the synthesis process were described in
a previous study [24].
The average hydrodynamic diameter of the anti-AFP
reagent was 57.3 ± 15.2 nm, as measured using a nanopar-
ticle size analyzer (Microtrac, Montgomeryville, PA, USA)
[19]. The superparamagnetic property was observed in a
magnetism-field curve obtained using a vibrating sample
magnetometer (EG&G PARC, Newnan, GA).
Development of a dual-imaging model of SSB
A dual-imaging model of SSB (Figure 1) composed of a
scanning probe and a SQUID sensor unit was developed
for optical and magnetic imaging, respectively. The pro-
posed model differs from traditional SSB systems that
measure magnetic signals alone. The unique design fea-
tures of this scanning probe unit include a dual-imaging
model mechanism, charge-coupled-device (CCD) mod-
ule (Singapsy Enterprise Corp., Taiwan), and first-order
vertical pickup coils surrounding the CCD module. The
dual-imaging model mechanisms were inserted into the
center of the circular excitation coil to construct the
scanning probe unit. To measure the actual AC sus-
ceptibility of the MNPs, the excitation field strength
and frequency of the excitation coil were set at 120 Oe
and 400 Hz, respectively. The reasons for selecting thisfrequency included the low power loading at low frequen-
cies for the same excitation coil, the interval between 360
and 420 Hz of low background noises [25], and the super-
ior characteristics of AC-susceptibility technology. The
field strength was selected to achieve sufficient sensitivity
for few MNPs targeted in rats; this is discussed in the sec-
tion describing the phantom test. Moreover, because the
product of these 2 excitation parameters was substantially
smaller than that required for animal biosafety [26], the
excitation exhibited low risk.
The CCD module with a focus of 1 cm was not influ-
enced by the magnetic fields, and it yielded an optical
video with a resolution of 0.2 in per pixel and a wide
angle of 40°. In general, the recorded video of each scan-
ning line was automatically converted to a panoramic
photograph. Subsequently, only the approximately central
2/3 region of the panoramic photograph was retained as a
single line image, which was then combined with the
other line images to construct a 2-dimensional optical
image. Moreover, light-emitting diodes were arranged
surrounding the CCD to provide adequate lighting
during the scanning processes, which involved close
distances between the scanning probe and sample. In
addition, the 7-cm-diameter scanning probe unit can
be operated similarly to an ultrasound probe with the
assistance of a 3-dimensional step motor similar to
that used in robotic scanners.
The dual-imaging model signals were acquired as
follows. The optical video from the CCD module was
recorded using a personal computer, although the
magnetic signal was too low to be directly sensed by
any current or voltage meter. The SQUID sensor unit
was composed of a high critical-temperature Tc SQUID
magnetometer (JSQ GmbH, Germany) in a dewar with
a liquid nitrogen refrigerant and a set of shielding cans.
Based on a typical conducting transfer coil [27] (as
depicted in Figure 1), the weak magnetic flux was
transferred from the pickup coils near the sample in an
unshielded environment to the input coil surrounding
the SQUID sensor, where it was amplified approximately
29-fold. The sensitivity of the entire dual-imaging model
SSB was approximately 3 pT/√Hz. The white noise of the
system is limited by the thermal noise of the normal-
conducting flux transformer [27]. The environmental
noise originated primarily from the concentric excitation
coil and slightly from the CCD and cooling fan attached
to the scanning probe unit.
The specificity of this dual-imaging model SSB in the
measurement of anti-AFP reagents was characterized by
conducting phantom and animal tests (Table 1).
Phantom test
In the phantom test, microtest tubes (Eppendorf
Corp., NY, USA) were filled with anti-AFP reagents at
Table 1 Phantom and animal tests in this study
Test type Test context
Phantom test • Anti-AFP reagent:
0.25 g in volume and 0.3, 0.2, 0.1, 0.01, 0.005 emu/g in concentration.
• Phantoms:
Micro test tubes were filled with anti-AFP reagent.
• Imaging:
The fused images composed of the magnetic image for the spatial distribution of anti-AFP MNPs
and the optic image of micro test tubes.
Animal tests • Dose of Anti-AFP reagent:
0.9 g in volume and 0.3 emu/g in concentration.
• Tumor rats:
Liver tumors were implanted on backs for 2 rats and in livers for 3 rats, separately.
Anti-AFP reagents were intravenously injected through tail veins.
• Imaging:
The 2 tumor rats with back tumors were imaged in a prone position by using the dual-model SSB at 0 h.
The 3 tumor rats implanted with liver tumors were imaged in a supine position at 0 h, 24 h, and with
their bellies opened at 24.5 h.
Both the stacked block and separated lobe livers of the 3 tumor rats implanted with liver tumors were
magnetically examined ex vivo.
• Tissue stain:
After identifying the red-spot and no-spot regions in separated lobe livers by this dual-model SSB,
small pieces of liver tissue in both regions for HE stain and AFP stain were performed.
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The samples weighed 0.25 g. Microtest tubes with a
diameter of less than 8 mm were selected to imitate
the size of early-stage tumors, and various concentrations
of AFP reagent were used to simulate the dynamics of
anti-AFP-meditated MNP-targeted tumors. In this test,
the anti-AFP reagents of 0.01 and 0.005 emu/g were lower
than the maximal MNP concentrations of approximately
0.045 emu/g in the livers of rats, as reported in the in vitro
results of previous studies [22,23].
The anti-AFP reagents were scanned at a distance of
2–36 mm between the scanning probe and the top of
the microtest tubes; this was approximately 31–65 mm
between the scanning probe and the surface of anti-AFP
reagents because the distance between the reagent sur-
face and the top of the microtest tube was 29 mm. To
calibrate the distance, 2 pieces of aluminum tape were
attached to the upper surface of the samples and to the
bottom surface of the scanning probe. Linking a copper
wire from each aluminum tape to a resistance meter en-
abled the zero distance to be determined on the basis of
the sound produced by the meter when the surface of
aluminum tape contacted the wire. The relative position
was controlled using the precision controller of a z-axis
step motor. Each scanning path was commenced and
terminated in free space, at least 1 cm from the animal
body. The signal baseline of each line was determined
according to the signal level in free space. Furthermore,
the constant scanning speed and step size were 5 mm/s
(for each line) and 5 mm, respectively. The pixel size of
each line in the magnetic image was 5 mm, which wasdetermined on the basis of the scanning path over
the sampling points, and the line interval was 5 mm
(Figure 2A). In other words, each pixel in the mag-
netic image was constructed according to the signal
of a scanning step. The preliminary test showed that
the measurement results of this scanning process were
identical to those obtained using a static process. The
remanence of the MNPs were omitted from the AC-
susceptibility measurement.
Animal test
Tumor masses of the GP7TB rat hepatoma cell line were
implanted into 5 male F344/NNarl rats (age = 5 wk),
which were divided into 2 groups. In one group, tumors
were grafted onto the backs of 2 rats to enable easy
identification of the tumors by using optical imaging; in
the other group, the tumors were implanted in the livers
of 3 rats to simulate real disease conditions. The tumors
were confirmed using tissue stains. After 3 wk of incu-
bation, anti-AFP reagents (dose = 0.9 g, concentration =
0.3 emu/g) were injected into the tail vein of these
tumor rats. After administering a mixture of oxygen gas
and isoflurane to anesthetize the rats, the tumor rats
were imaged using the proposed dual-imaging model
SSB. The imaging conditions were identical to those
used in the phantom test. All experiments were conducted
according to the animal care guidelines of National
Taiwan University.
To verify the feasibility of tumor positioning by using
the dual-model SSB, the tumor rats with back tumors
were imaged in a prone position immediately before being
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after the injection (the tumor rat as shown in Figure 3).
Each scanning time was approximately 2.5 minutes.
Similarly, to investigate the navigation of the interior
liver tumors within the liver lobes, the 3 tumor rats with
the implanted liver tumors were imaged in a supine pos-
ition at 0 h, 24 h, and with their abdomens exposed at
24.5 h (Rat B1 as shown in Figure 4A). Each scanning
time was approximately 8 minutes. The tumor rats were
sacrificed and their livers were immersed in diluted for-
malin (concentration = 10%) for 1 wk. Both the stacked
block and separated liver lobes were magnetically exam-
ined ex vivo (Rat B1 as shown in Figure 4B). Each scan-
ning time was approximately 2 minutes. Opposite to the
stacked livers, each liver lobe was observed at the same
sample distance. After identifying the red-spot and no-
spot regions in the separated liver lobes, small pieces of
liver tissue in both regions were subjected to HE and AFP
staining in the National Laboratory Animal Center,
College of Medicine, at National Taiwan University.
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